SEC Form 4 · accession 0001188919-26-000015
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ted W Love
Director
Period of report
Aug 31, 2026
Accepted (ET)
Sep 2, 2026 · 5:28 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Aug 31, 2026 | F | 6 | $244.0633 | D | 3,126 | D | |
| Ordinary Shares | Aug 31, 2026 | F | 737 | $241.3899 | D | 2,389 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.